Development of enhanced buccal films with Actinidia arguta fruit extract for oral mucositis prevention: from in vitro buccal models to ex vivo investigations
DOI:
https://doi.org/10.48797/sl.2024.139Keywords:
Selected Oral CommunicationAbstract
Background: Oral mucositis (OM) is a common side effect of cancer treatments such as chemotherapy [1], being characterized by disruption of the oral mucosa integrity, inflammation, and pain [1,2]. The treatment strategies to prevent and treat OM are still unsatisfactory, leading to the search of new active compounds, particularly from natural sources, such as Actinidia arguta fruits [1]. A. arguta fruit, commonly known as kiwiberry, has been associated with different therapeutic properties and pro-healthy benefits, particularly antioxidant, anti-inflammatory and anticancer effects [3,4], due to the fruit’s outstanding content in phenolic compounds, vitamins, and organic acids [3,4]. Objective: The aim of this study was to develop buccal films with A. arguta fruit extract as active ingredient to prevent OM symptoms. Methods: The films were prepared by solvent casting employing 1% of HPMC K100 LV EP, 2.5% glycerin, and A. arguta extract as solvent, previously prepared by Ultrasound-Assisted Extraction [4]. Results: Different films parameters were assessed, namely physical features (weight: 194.8 mg; thickness: 0.37 mm; disintegration time: 15.05 min; moisture content: 10.53%; swelling capacity: 55.95%), mechanical properties (resistance to extension: 10.11 N; percent of elongation: 36.10%; Young’s modulus: 0.0034 MPa) and antioxidant/antiradical activities (TPC = 6.46 mg GAE/g film; FRAP = 49.45 µmol FSE/g film; ABTS = 3.74 mg AAE/g film; DPPH = 4.90 mg TE/g film). In vitro cell assays attested the absence of negative effects on HSC-3 and TR146 oral cell lines. Most important, the compounds release profile was assessed through in vitro cell models (TR146) and ex vivo assay with porcine mucosa coupled to LC/DAD-ESI-MS quantification. The results revealed high permeation of rutin (88.32%), quercetin-3-O-glucoside (84.95%) and catechin (79.74%). Conclusions: Overall, these results highlight the significant potential and safety of buccal films with A. arguta fruit extract to prevent OM condition.References
1. Ferreira, A.S., et al. Natural Products for the Prevention and Treatment of Oral Mucositis - A Review. Int J Mol Sci 2022, 23, 4385.
2. Pulito, C., et al. Oral mucositis: the hidden side of cancer therapy. J Exp Clin Cancer Res 2020, 39, 210.
3. Silva, A.M., et al. Infusions and decoctions of dehydrated fruits of Actinidia arguta and Actinidia deliciosa: Bioactivity, radical scavenging activity and effects on cells viability. Food Chem 2019, 289, 625-634.
4. Macedo, C., et al. Insights into the polyphenols extraction from Actinidia arguta fruit (kiwiberry): A source of pro-healthy compounds. Sci Hortic 2023, 313, 111910.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Filipa Teixeira, Ana Margarida Silva, Catarina Macedo, Berta Estevinho, Stefania Sut, Stefano Dall’Acqua, Cristina Delerue-Matos, Paulo C. Costa, Francisca Rodrigues
This work is licensed under a Creative Commons Attribution 4.0 International License.
In Scientific Letters, articles are published under a CC-BY license (Creative Commons Attribution 4.0 International License), the most open license available. The users can share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as they give appropriate credit, provide a link to the license, and indicate if changes were made (read the full text of the license terms and conditions of use).
The author is the owner of the copyright.